MX2009005793A - Interferon alpha-induced pharmacodynamic markers. - Google Patents
Interferon alpha-induced pharmacodynamic markers.Info
- Publication number
- MX2009005793A MX2009005793A MX2009005793A MX2009005793A MX2009005793A MX 2009005793 A MX2009005793 A MX 2009005793A MX 2009005793 A MX2009005793 A MX 2009005793A MX 2009005793 A MX2009005793 A MX 2009005793A MX 2009005793 A MX2009005793 A MX 2009005793A
- Authority
- MX
- Mexico
- Prior art keywords
- ifnî
- induced
- patients
- ifn
- methods
- Prior art date
Links
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
The present invention encompasses type-1 IFN and IFNα-induced PD marker expression profiles, kits, and methods for identifying such IFNα-induced PD marker expression profiles. The type-I IFN and IFNα-induced PD marker expression profiles may also be used in, for example, methods of treating patients having a type-I IFN or IFNα- mediated disorder, methods of monitoring disease progression of patients receiving treatment with a therapeutic agent that binds to and modulates IFNα activity, identifying patients as candidates to receive a therapeutic that binds to and neutralizes IFNα activity, and in diagnosing or providing a prognosis to patients having IFNα-induced disorders.
Applications Claiming Priority (13)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US87300806P | 2006-12-06 | 2006-12-06 | |
US90776207P | 2007-04-16 | 2007-04-16 | |
US92422007P | 2007-05-03 | 2007-05-03 | |
US92421907P | 2007-05-03 | 2007-05-03 | |
US92458407P | 2007-05-21 | 2007-05-21 | |
US96018707P | 2007-09-19 | 2007-09-19 | |
US99617407P | 2007-11-05 | 2007-11-05 | |
US99617607P | 2007-11-05 | 2007-11-05 | |
US99621907P | 2007-11-06 | 2007-11-06 | |
US99682007P | 2007-12-06 | 2007-12-06 | |
PCT/US2007/024947 WO2008070137A2 (en) | 2006-12-06 | 2007-12-06 | Interferon alpha-induced pharmacodynamic markers |
PCT/US2007/024941 WO2008070135A2 (en) | 2006-12-06 | 2007-12-06 | Methods of treating systemic lupus erythematosus |
US90776709P | 2009-04-16 | 2009-04-16 |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2009005793A true MX2009005793A (en) | 2009-07-10 |
Family
ID=41559078
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2009005793A MX2009005793A (en) | 2006-12-06 | 2007-12-06 | Interferon alpha-induced pharmacodynamic markers. |
Country Status (1)
Country | Link |
---|---|
MX (1) | MX2009005793A (en) |
-
2007
- 2007-12-06 MX MX2009005793A patent/MX2009005793A/en active IP Right Grant
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2008070137A3 (en) | Interferon alpha-induced pharmacodynamic markers | |
WO2008137838A3 (en) | Interferon alpha-induced pharmacodynamic markers | |
CY1118566T1 (en) | DIAGNOSIS USING INTERFERENCE TYPE 1 | |
WO2008079326A3 (en) | Methods for using and identifying modulators of delta-like 4 | |
BRPI0512500A (en) | treatment or conditions involving demyelination | |
MX2009012625A (en) | Methods of treating, diagnosing and detecting fgf21-associated disorders. | |
CY1111714T1 (en) | Binding Protein Growth Factor (HGF) Binding Proteins. | |
SG147442A1 (en) | Methods and reagents for the treatment of immunoinflammatory disorders | |
WO2007109236A8 (en) | Microrna fingerprints during human megakaryocytopoiesis | |
WO2007044860A3 (en) | Diabetes-associated markers and methods of use thereof | |
WO2009100342A3 (en) | Disease markers and uses thereof | |
MX349787B (en) | Oral dosage forms including an antiplatelet agent and an acid inhibitor. | |
UY28933A1 (en) | COMBINATIONS THAT INCLUDE ANTIMUSCARINIC AGENTS AND BETA-ADRENERGIC AGONISTS | |
MX2009012722A (en) | Genetic variants on chr 5pl2 and 10q26 as markers for use in breast cancer risk assessment, diagnosis, prognosis and treatment. | |
RS20050035A (en) | Therapies for renal failure using interferon-betha | |
TW200531679A (en) | Methods of modulating cytokine activity; related reagents | |
ATE553778T1 (en) | ANTIBODIES SPECIFIC TO HUMAN HEPCIDIN | |
TW200528117A (en) | Methods and reagents for the treatment of proliferative diseases | |
ATE424560T1 (en) | MARKER FOR NEUROMYELITIS OPTICA | |
WO2005113831A3 (en) | Biomarkers for multiple sclerosis and methods of use thereof | |
PL1889920T3 (en) | In vitro cancer therapy compound identification method | |
RS51069B (en) | Use of oxycodone for treating visceral pain | |
EP2175879A4 (en) | Treatment of prion protein related diseases | |
UA96926C2 (en) | Use of sdf-1 for the treatment and/or prevention of neurological diseases | |
ATE555814T1 (en) | RADIOACTIVE AGENTS FOR IN VIVO PET IMAGING OF CCR5 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |